GSK picks ex-Tesco chief Lewis to chair consumer healthcare arm -source
Reuters
Published Dec 19, 2021 12:47PM ET
Updated Dec 19, 2021 03:45PM ET
By Anirudh Saligrama
(Reuters) -British drugmaker GlaxoSmithKline (NYSE:GSK) Plc has picked Dave Lewis, former chief executive of Tesco (OTC:TSCDY) Plc, to chair its consumer healthcare unit, which is due to be spun off next year, a source familiar with the matter said on Sunday.
Confirmation of Lewis's appointment as non-executive chairman of the arm that owns brands including Sensodyne toothpaste could come as soon as Monday, the source told Reuters.
Lewis left Tesco in September after six years as CEO.
GSK owns 68% of the unit and Pfizer Inc (NYSE:PFE) the remainder. In July, GSK said its current head, Brian McNamara, would take over as CEO once it was spun off.
GSK said in October it was on track to spin the unit off next year at a valuation of upwards of 40 billion pounds ($53 billion).
($1 = 0.7551 pounds)
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.